Wang Xinna, Zhao Hongfei, Liu Liming, Niu Ping, Zhai Chao, Li Jinjian, Xu Qiaoli, Zhao Dexi
Changchun University of Traditional Chinese Medicine, Changchun, Jilin, 130117 China.
Administration of Traditional Chinese Medicine of Jilin Province, Changchun, Jilin, 130051 China.
Chin Med. 2020 Sep 29;15:105. doi: 10.1186/s13020-020-00386-y. eCollection 2020.
Migraine is painful disease in which neurotransmitters related to pain transmission play an important role. Hejie Zhitong prescription (HJZT) has been used in the clinic as an effective prescription for the treatment of migraine for many years. Our team aimed to further explore its antimigraine mechanism based on previous research results and to explore the inhibitory effect of HJZT on the transmission of pain related to nitroglycerine (NTG)-induced migraine as well as the synergistic effect of HJZT with pentobarbital sodium on promoting sleep.
Sixty mice were randomly assigned to groups and received the corresponding interventions. Sleep latency and sleep time were recorded to calculate the incidence of sleep. Forty-eight Wistar rats were randomly assigned and administered an intervention corresponding to their group. Calcitonin gene-related peptide (CGRP), serotonin (5-HT), substance P (SP), and cholecystokinin (CCK) levels were measured using ELISAs. Levels of the cannabinoid receptor type 1 (CB1R) and cyclooxygenase-2 (COX-2) protein were assessed using immunohistochemistry. The expression of the CGRP and CCK mRNAs in the midbrain and trigeminal ganglion (TG) were measured using real-time quantitative PCR.
HJZT promoted the occurrence of sleep in mice. HJZT downregulated COX-2 expression in the midbrain and TG of rats but upregulated the expression of the CB1R, and decreased the plasma level of the CGRP protein and expression of its mRNA in the midbrain and TG. It also downregulated the expression of the CCK mRNA in the midbrain and TG. The high-dose HJZT treatment increased plasma 5-HT levels, but did not induce changes in the plasma levels of the SP or CCK protein.
HJZT exerts a synergistic effect with pentobarbital sodium on promoting sleep. As for anti-migraine, HJZT can inhibits the expression of nociceptive transmission-associated neurotransmitters, including 5-HT, CGRP and CCK, which may be related to its upregulation of CB1R and downregulation of COX-2.
偏头痛是一种疼痛性疾病,其中与疼痛传递相关的神经递质起着重要作用。和剂止痛方(HJZT)多年来一直作为治疗偏头痛的有效方剂应用于临床。我们的团队旨在基于先前的研究结果进一步探索其抗偏头痛机制,并探讨HJZT对硝酸甘油(NTG)诱导的偏头痛相关疼痛传递的抑制作用以及HJZT与戊巴比妥钠对促进睡眠的协同作用。
将60只小鼠随机分组并接受相应干预。记录睡眠潜伏期和睡眠时间以计算睡眠发生率。将48只Wistar大鼠随机分组并给予相应组别的干预。使用酶联免疫吸附测定法(ELISA)测量降钙素基因相关肽(CGRP)、5-羟色胺(5-HT)、P物质(SP)和胆囊收缩素(CCK)的水平。使用免疫组织化学评估1型大麻素受体(CB1R)和环氧合酶-2(COX-2)蛋白的水平。使用实时定量聚合酶链反应(PCR)测量中脑和三叉神经节(TG)中CGRP和CCK信使核糖核酸(mRNA)的表达。
HJZT促进小鼠睡眠的发生。HJZT下调大鼠中脑和TG中COX-2的表达,但上调CB1R的表达,并降低中脑和TG中CGRP蛋白的血浆水平及其mRNA的表达。它还下调中脑和TG中CCK mRNA的表达。高剂量HJZT治疗可提高血浆5-HT水平,但不会引起血浆SP或CCK蛋白水平的变化。
HJZT与戊巴比妥钠在促进睡眠方面具有协同作用。至于抗偏头痛,HJZT可以抑制与伤害性传递相关的神经递质的表达,包括5-HT、CGRP和CCK,这可能与其上调CB1R和下调COX-2有关。